Petros Konofaos, PhD
Plastic and Reconstructive Surgery · Galveston, TXNPI 1720364367
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Axogen accounts for 62.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $7,229 and has fallen 77.0% since, to $1,660 in 2025.
Across 58 payments — averaging $191.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$7K
- AbbVie$2K
- Musculoskeletal Transplant Foundation Inc.$313
- Acell, Inc.$229
- Alafair Biosciences, Inc.$221
- Acera Surgical, Inc.$188
- plus $1K from 12 others
Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axogen$5K
What the payments were for
- Consulting fees$6,15056%
- Travel & lodging$1,35712%
- Food & beverage$3,57332%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 12 | $6,909 |
| AbbVie(2 entities) | 17 | $2,106 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $313 |
| Acell, Inc. | 2 | $229 |
| Alafair Biosciences, Inc. | 4 | $221 |
| Acera Surgical, Inc. | 2 | $188 |
| Kerecis Limited | 2 | $161 |
| Sientra, Inc. | 1 | $146 |
| Polynovo North America LLC | 2 | $143 |
| Mentor Worldwide LLC | 1 | $135 |
| Baxter Healthcare | 1 | $125 |
| Medline Industries LP | 1 | $106 |
| Acumed LLC | 2 | $94 |
| Checkpoint Surgical, Inc | 1 | $80 |
| Kls-martin L.p. | 2 | $53 |
| Stryker | 2 | $27 |
| Misonix Inc | 1 | $25 |
| Biotissue Holdings Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$1,428
- Kerecis Omega3 SurgiClose$403
- Restrata Wound Matrix$157
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$146
- VersaWrap$144
- AVANCE NERVE GRAFT$143
- ARTOURA Breast Tissue Expander$135
- MENTOR MemoryGel Resterilizable Gel Sizer$135
- Kerecis Omega3 GraftGuide$134
- Kerecis Omega3 Marigen$134
- No Related Product$125
- ALLODERM$120
- AxoGuard Nerve Connector$116
- AxoGuard Nerve Protector$116
- Dermatology and Wound Care$106
How this compares
$11,080 in reported general payments places this provider in the 80th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Galveston
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Alina SholarAustin$110K
- Ashley SteinbergBellaire$102K
- Eric MinnsLubbock$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.